With two years of experience selling Alzheimer’s disease antibody Leqembi so far under Eisai’s belt, the Japanese drugmaker ...

The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

“[T]he Leqembi business is continuously growing stronger,” Eisai’s CEO, Tatsuyuki Yasuno, added in a recent interview with Fierce Pharma, noting that the drug has now reached 13,500 patients ...

Japanese drugmaker Eisai Inc. will lay off 57 employees in Nutley between the end of March and May, public records show, as the pharmaceutical company shaves off 7% of its U.S. workforce.

Japanese pharmaceutical company Eisai has announced it is expanding into Russia, by establishing a new sales and marketing operation in Moscow. Eisai’s market entry will be based on launching ...